Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06205706
Title BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioInvent International AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | ESP | DNK | DEU

Facility Status City State Zip Country Details
Yale Cancer Center RECRUITING New Haven Connecticut 06519 United States Details
Rigshospitalet RECRUITING Copenhagen Denmark Details
Charité Universitätsmedizin Berlin RECRUITING Berlin Germany Details
Universitätsklinikum Essen NOT_YET_RECRUITING Essen Germany Details
Uniwersytecki Szpital Kliniczny RECRUITING Poznań Poland Details
Instytut Centrum Zdrowia Matki Polki RECRUITING Łódź Poland Details
Hospital HM Nou Delfos RECRUITING Barcelona 08023 Spain Details
HM Sanchinarro RECRUITING Madrid Spain Details
Hospital Fundacion Jimenez Diaz RECRUITING Madrid Spain Details
Hospital universitario Virgen del Rocio RECRUITING Sevilla Spain Details
Lund University Hospital NOT_YET_RECRUITING Lund Sweden Details
Karolinska University Hospital, Solna RECRUITING Stockholm Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field